API CDMO Market Growth Drivers and Opportunities
The active pharmaceutical ingredient (API) CDMO market is a crucial and rapidly growing segment within the pharmaceutical industry, driven by heightened R&D investments, chronic disease prevalence, and the surge in generic drugs as patents expire. Following the pandemic, transformative innovations, regional growth variances, and technological advancements are reshaping this dynamic market landscape, offering strategic opportunities […]
3 minute read